A Multicenter Study Comparing the Analgesic Effects and Safety of ABT-639 Compared to Placebo in Subjects With Diabetic Neuropathic Pain
Public ClinicalTrials.gov record NCT01345045. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo and Active Controlled Study Comparing the Analgesic Efficacy and Safety of ABT-639 to Placebo in Subjects With Diabetic Neuropathic Pain
Study identification
- NCT ID
- NCT01345045
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- AbbVie (prior sponsor, Abbott)
- Industry
- Enrollment
- 193 participants
Conditions and interventions
Conditions
Interventions
- ABT-639 Drug
- pregabalin Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2011
- Primary completion
- Sep 30, 2011
- Completion
- Sep 30, 2011
- Last update posted
- Jan 7, 2013
2011
United States locations
- U.S. sites
- 19
- U.S. states
- 11
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site Reference ID/Investigator# 51807 | Little Rock | Arkansas | 72204 | — |
| Site Reference ID/Investigator# 51946 | Anaheim | California | 92801 | — |
| Site Reference ID/Investigator# 51468 | Long Beach | California | 90806 | — |
| Site Reference ID/Investigator# 52744 | Walnut Creek | California | 94598 | — |
| Site Reference ID/Investigator# 51079 | Clearwater | Florida | 33765 | — |
| Site Reference ID/Investigator# 51076 | Hialeah | Florida | 33012 | — |
| Site Reference ID/Investigator# 51945 | Hollywood | Florida | 33021 | — |
| Site Reference ID/Investigator# 51077 | Ocala | Florida | 34471 | — |
| Site Reference ID/Investigator# 51078 | Orlando | Florida | 32806 | — |
| Site Reference ID/Investigator# 51804 | Brockton | Massachusetts | 02301 | — |
| Site Reference ID/Investigator# 51263 | St Louis | Missouri | 63141 | — |
| Site Reference ID/Investigator# 51268 | St Louis | Missouri | 63141 | — |
| Site Reference ID/Investigator# 51302 | Omaha | Nebraska | 68131 | — |
| Site Reference ID/Investigator# 51271 | Flushing | New York | 11365 | — |
| Site Reference ID/Investigator# 52743 | Portland | Oregon | 97239 | — |
| Site Reference ID/Investigator# 51806 | Altoona | Pennsylvania | 16602 | — |
| Site Reference ID/Investigator# 51265 | Tipton | Pennsylvania | 16684 | — |
| Site Reference ID/Investigator# 51548 | Dallas | Texas | 75231 | — |
| Site Reference ID/Investigator# 51269 | Renton | Washington | 98055 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01345045, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 7, 2013 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01345045 live on ClinicalTrials.gov.